Palvella Therapeutics (PVLA) Receivables - Other (2019 - 2024)
Historic Receivables - Other for Palvella Therapeutics (PVLA) over the last 4 years, with Q3 2024 value amounting to $506000.0.
- Palvella Therapeutics' Receivables - Other changed N/A to $506000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $506000.0, marking a year-over-year change of. This contributed to the annual value of $3.1 million for FY2023, which is 3416.47% down from last year.
- As of Q3 2024, Palvella Therapeutics' Receivables - Other stood at $506000.0.
- Over the past 5 years, Palvella Therapeutics' Receivables - Other peaked at $4.8 million during Q4 2022, and registered a low of $506000.0 during Q3 2024.
- Over the past 3 years, Palvella Therapeutics' median Receivables - Other value was $3.1 million (recorded in 2024), while the average stood at $2.9 million.
- Over the last 5 years, Palvella Therapeutics' Receivables - Other had its largest YoY gain of 3416.47% in 2023, and its largest YoY loss of 3416.47% in 2023.
- Quarter analysis of 3 years shows Palvella Therapeutics' Receivables - Other stood at $4.8 million in 2022, then plummeted by 34.16% to $3.1 million in 2023, then tumbled by 83.89% to $506000.0 in 2024.
- Its Receivables - Other was $506000.0 in Q3 2024, compared to $3.0 million in Q2 2024 and $3.1 million in Q1 2024.